OverviewSuggest Edit

Healx is an AI-powered technology company accelerating the discovery and development of rare disease treatments. Its services are offered through a technology platform that helps medical researchers match potential treatments to rare conditions and patients by the usage of data analytics, including machine learning and computational biology techniques, alongside scientific literature analysis.

TypePrivate
Founded2014
HQCambridge, GB
Websitehealx.io
Employee Ratings4.4

Latest Updates

Employees (est.) (May 2020)57(+6%)
Revenue (FY, 2018)£157 K(+75%)

Key People/Management at Healx

Tim Guilliams

Tim Guilliams

Co-Founder & CEO
Kate Hilyard

Kate Hilyard

Chief Operating Officer
David Campbell

David Campbell

Finance Director
Michael Motskin

Michael Motskin

Head of Digital Strategy
Ian Roberts

Ian Roberts

Director of Therapeutic Technology
Neil Thompson

Neil Thompson

Chief Scientific Officer
Show more

Healx Office Locations

Healx has an office in Cambridge
Cambridge, GB (HQ)
Charter House, 66-68 Hills Rd
Show all (1)

Healx Financials and Metrics

Summary Metrics

Founding Date

2014

Healx total Funding

$66 m

Healx latest funding size

$56 m

Time since last funding

8 months ago

Healx investors

Healx's latest funding round in October 2019 was reported to be $56 m. In total, Healx has raised $66 m
Show all financial metrics

Healx Revenue

Healx's revenue was reported to be £157.01 k in FY, 2018 which is a 74.6% increase from the previous period.
GBP

Revenue (FY, 2018)

157.0k

Revenue growth (FY, 2017 - FY, 2018), %

74.6%

Gross profit (FY, 2018)

85.3k

Gross profit margin (FY, 2018), %

54.3%

Net income (FY, 2018)

(1.9m)

EBIT (FY, 2018)

(2.3m)

Cash (31-Dec-2018)

5.5m
GBPFY, 2016FY, 2017FY, 2018

Revenue

44.2k89.9k157.0k

Revenue growth, %

103%75%

Cost of goods sold

30.3k71.7k

Gross profit

59.6k85.3k
GBPFY, 2016FY, 2017FY, 2018

Cash

1.2m529.9k5.5m

Accounts Receivable

62.1k6.7k

Current Assets

1.4m728.3k6.2m

PP&E

10.8k33.8k40.5k
GBPY, 2018

Revenue/Employee

5.4k
Show all financial metrics

Healx Operating Metrics

Oct, 2019May, 2020

Programs Launched

10

Trademarks Pending

3
Show all operating metrics

Healx Online and Social Media Presence

Embed Graph

Healx News and Updates

Healx trains AI to find Covid-19 combination therapies

Healx is using its artificial intelligence platform to develop drug combinations from approved medicines to help treat Covid-19.

Healx links with CTF to develop neurofibromatosis therapies

Cambridge, UK-based Healx has formed a new partnership with US and Europe-based patient group the Children’s Tumor Foundation (CTF) to progress new AI-derived therapies for neurofibromatosis (NF).

Healx fights rare disorder via new global alliance

Healx, the AI-powered technology business repurposing drugs to fight rare diseases, has forged a new global alliance that could hold significant benefits for sufferers of an uncommon genetic disorder.

Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease

The AI-driven drug repurposing company Healx has teamed up with the global Children’s Tumor Foundation (CTF) to develop new treatments for the genetic disease neurofibromatosis type 1, right after the FDA approved the first-ever drug for the condition.

Healx will use AI to seek combination therapies to treat Covid-19

Healx, which runs an AI drug discovery platform, wants to predict which known drugs could be used to treat Covid-19.

AI 'CAN SPEED UP DRUG DISCOVERY BY A DECADE'

Cambridge-based Healx has created Healnet, an AI drug discovery platform which uses a suite of complex AI algorithms to quickly and accurately predict potential new drug-disease relationships from data.
Show more

Healx Blogs

Healx commits $20 million to launch Rare Treatment Accelerator programme; Appoints Dr Bruce Bloom as Chief Collaboration Officer to lead initiative

Cambridge, UK – 21 November 2019 – Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that applications are now being accepted for its Rare Treatment Accelerator (RTA). The programme focuses on finding new treatments for rare d…

Michale Bouskila-Chubb recognised in 50 Movers and Shakers in BioBusiness Report

Michale has been featured in recognition of her contribution to Healx’s business through the negotiation and closing of the company’s first pharma deals, navigating new issues such as data use and IP in drug discovery deals using artificial intelligence (AI). In addition to this, Michale has been in…

Healx scientists present two new papers at EMNLP 2019 in Hong Kong

Poster #1: Deep Bidirectional Transformers for Relation Extraction without Supervision  NLP Scientist, Yannis Papanikolaou, will be presenting his work on relationship extraction, using a fine-tuning of Google’s BERT language model. Being able to successfully extract relationships despite scarce dat…

Healx secures $56m in Series B financing, launches global accelerator programme for rare diseases

Cambridge, UK – 16 October, 2019 – Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that it has raised $56 million in a Series B financing round, led by one of Europe’s largest VC firms Atomico and joined by Intel Capital, Gl…

Healx partners with the ICR to develop potential new AI-derived treatments for rare childhood cancer, DIPG

We are delighted to announce a collaboration with scientists at The Institute of Cancer Research, London (ICR) to discover new possible ways of treating diffuse intrinsic pontine glioma (DIPG), a life-limiting childhood brain cancer for which no treatments currently exist. The ICR is an internationa…
Show more

Healx Frequently Asked Questions

  • When was Healx founded?

    Healx was founded in 2014.

  • Who are Healx key executives?

    Healx's key executives are Tim Guilliams, Kate Hilyard and David Campbell.

  • How many employees does Healx have?

    Healx has 57 employees.

  • What is Healx revenue?

    Latest Healx annual revenue is £157 k.

  • What is Healx revenue per employee?

    Latest Healx revenue per employee is £2.8 k.

  • Who are Healx competitors?

    Competitors of Healx include Huma, AI Therapeutics and 1910 Genetics.

  • Where is Healx headquarters?

    Healx headquarters is located at Charter House, 66-68 Hills Rd, Cambridge.

  • Where are Healx offices?

    Healx has an office in Cambridge.

  • How many offices does Healx have?

    Healx has 1 office.